SCHEMBL2715344

SCHEMBL2715344

CS(=O)(=O)c1ccccc1-c1c(CCN)nc2ccccn2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.49
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
BRD9 Q9H8M2 1/20 0.39
BAZ2B Q9UIF8 1/20 0.39
BAZ2A Q9UIF9 1/20 0.39
MAPT P10636 3/20 0.38
POLB P06746 1/20 0.38
DPP4 P27487 1/20 0.37
HTR6 P50406 1/20 0.37
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 5/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL890536 0.79 PIK3CD (0.59) PIK3CDHSP90AA1HSP90AB1BRD9BAZ2B
SCHEMBL890481 0.74 PIK3CD (0.54) PIK3CDHSP90AA1HSP90AB1BRD9BAZ2B
SCHEMBL3959308 0.70 MAPT (0.53) MAPTALDH1A1KDM4EGLAGAA
SCHEMBL890633 0.69 PIK3CD (0.68) PIK3CD
SCHEMBL14106369 0.68 MAPT (0.51) MAPTPOLBDPP4ALDH1A1KDM4E
SCHEMBL3961340 0.68 MAPT (0.53) MAPTPOLBALDH1A1KDM4EGLA
SCHEMBL3955336 0.65 ENPP2 (0.48) MAPTPOLBKDM4EGAASMN1; SMN2
SCHEMBL3959106 0.64 ENPP2 (0.50) MAPTPOLBALDH1A1KDM4EGAA
SCHEMBL3955153 0.64 MAPT (0.51) MAPTPOLBDPP4ALDH1A1KDM4E
SCHEMBL18305006 0.64 BAZ2B (0.46) PIK3CDHSP90AA1HSP90AB1BRD9BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445898-A2 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES AS PI3K INHIBITORS Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151735-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed